Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy
Contact Info
Unit 266, 267 & 268, Tower B1, Spaze Itech Park Sohna Road Gurugram, Haryana 122018 connect@complinity.com +91 8181 900 600
Follow Us

A Multi-Concept Theme for Digital Agencies and Startups

8181 900 600 Request a Demo Login
logo dark logo light logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Contact Sales
logo dark logo light logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Contact Sales
Mobile Logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Industry specific-Medical Central Ministry of Environment, Forest & Climate change Drugs and Cosmetics Act, 1940

WHO Alert on falsified DEFITELIO (DEFIBROTIDE) 80 mg/ml concentrate for solution for infusion, B. No. 20G20A, Exp date 08/2024 mfg by: Gentium Srl and identified in India

06-Sep-2023 | File No. Enforc-11015(12)/1/2023-eoffice (Computer No. 115)

Central Drugs Standard Control Organization has issued an Alert Notification regarding a WHO Alert concerning falsified DEFITELIO (DEFIBROTIDE) 80 mg/ml concentrate for a solution for infusion, Batch No. 20G20A, with an expiry date of 08/2024, manufactured by Gentium Srl and identified in India. According to the Notification, the World Health Organization (WHO) released Medical Product Alert No. 7/2023 on 04.09.2023, regarding the falsified product DEFITELIO (DEFIBROTIDE) 80 mg/ml concentrate for solution for infusion, Batch No. 20G20A, with an expiry date of 08/2024, manufactured by Gentium Srl. This falsified product was detected in India in April 2023 and in Turkey in July 2023, and it was supplied through unauthorized channels. Due to the significant public health threat posed by these falsified products and the risks associated with their use in multiple countries and regions, the WHO Global Surveillance and Monitoring System (GSMS) issued a Medical Product Alert to report its detection in the WHO Regions of Europe and South East Asia. DEFITELIO does not have marketing authorization in India and Turkey. Risks associated with falsified DEFITELIO include ineffective treatment of patients and other serious health risks due to its intravenous administration, which could be life-threatening in some cases. The following advisory is provided: a. To Doctors and Healthcare Professionals: Doctors and healthcare professionals should prescribe with caution and educate patients to report any adverse drug reactions (ADRs). b. To Consumers and Patients: Exercise caution and only procure medical products from authorized sources with proper purchase invoices. c. To Regulatory Authorities (All States/UTs Drugs Controllers and all Zonal and Sub-Zonal Offices of CDSCO, all Port Offices of CDSCO): Instruct your officers to closely monitor the movement, sale, distribution, and stock of the mentioned drug products in the market.

Upgrade to paid version to access the Notification, Circular & Rules along with the checklist

Get Legal Updates in your email

Request a Demo

Recent Posts in Corporate Laws

Corporate Laws

SEBI issues press release on “Samajh Se Investing Simple” Campaign under Project Jagrook

05-Oct-2026 | PR No.61/2026

SEBI has issued press release on “Samajh Se Investing Simple” Campaign under Project Jagrook Through this Press Release, The ca

Read More
Corporate Laws

NSE reiterate the circular issued by SEBI regarding Introduction of Credit Risk-o-Meter as an additional disclosure mechanism for debt securities

08-Oct-2026 | NSE/COMP/76794

NSE has reiterated the circular issued by SEBI regarding Introduction of Credit Risk-o-Meter as an additional disclosure mechanism for debt

Read More
Corporate Laws

NSDL reiterate the circular issued by SEBI regarding Master Circular for Debenture Trustees

08-Oct-2026 | NSDL/CIR/II/50/2026

NSDL has reiterated the circular issued by SEBI regarding Master Circular for Debenture Trustees Through this circular, Issuers and RTAs ar

Read More
Corporate Laws

BSE issues circular regarding Cyber Audit on Half Yearly basis for Audit Period ending September 30, 2026

08-Oct-2026 | 20261008-51

BSE has issued circular regarding Cyber Audit on Half Yearly basis for Audit Period ending September 30, 2026 Through this circular, with r

Read More

Recent Posts

Corporate Laws

SEBI issues press release on “Samajh Se Investing Simple” Campaign under Project Jagrook

05-Oct-2026 | PR No.61/2026

SEBI has issued press release on “Samajh Se Investing Simple” Campaign under Project Jagrook Through this Press Release, The ca

Read More
Industry specific-Medical

Government of Chhattisgarh has declared snakebite and death due to snakebite as notifiable diseases

24-Sep-2026 | No. GENCOR/707/2025-HEALTH SECTION-1

The Government of Chhattisgarh has declared snakebite and death due to snakebite as notifiable diseases throughout the State under Sections

Read More
Labour Laws

Bihar Government Notification on Implementation of Section 27 and Schedule VII of the Bihar Ease of Doing Business Act 2026 for Dispensation of Duplicate Licences

09-Oct-2026 | No- DMSME/Deregulation vivid/11/2026-2495—1.

The Department of Industries, Government of Bihar, has notified the implementation of Section 27 read with Schedule VII of the Bihar Ease of

Read More
Taxation

CBIC issues circular regarding clarification on the scope of “Power Bank” for Basic Customs Duty Concession on Battery Energy Storage Systems

09-Oct-2026 | Circular No. 45/2026-customs

CBIC has issued circular regarding clarification on the scope of “Power Bank” for Basic Customs Duty Concession on Battery Energ

Read More
Request a Demo

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy

Complinity Logo Transparent

Complinity is a comprehensive cloud-based Compliance Management Software that helps track and monitor statutory and regulatory compliances.

Quick Links
  • Compliance Software
  • Regulatory Compliance Software
  • Statutory Compliance Software
  • Compliance Tracking Software
  • Legal Updates
Contact Info
Unit 266, 267 & 268, Tower B1
Spaze Itech Park, Sohna Road
Gurugram, Haryana 122018
connect@complinity.com
+91 8181 900 600

Request a Demo

© 2026 Complinity Technologies Private Limited. | Privacy Policy | Data Processing Addendum

Design & Developed By  Infinite IT Solutions

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy
Powered by EssentialPlugin

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy

Thank You for your interest in Complinity. Your CV has been forwarded to HR.
In case your profile is shortlisted, HR shall contact you.